Literature DB >> 31563225

An Update: Pathophysiology of Migraine.

Peter J Goadsby1, Philip R Holland2.   

Abstract

Migraine is the most common disabling primary headache globally. Attacks typically present with unilateral throbbing headache and associated symptoms including, nausea, multisensory hypersensitivity, and marked fatigue. In this article, the authors address the underlying neuroanatomical basis for migraine-related headache, associated symptomatology, and discuss key clinical and preclinical findings that indicate that migraine likely results from dysfunctional homeostatic mechanisms. Whereby, abnormal central nervous system responses to extrinsic and intrinsic cues may lead to increased attack susceptibility.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aura; Cortical spreading depression; Headache; Homeostatic networks; Migraine; Pain; Trigeminal; Trigeminovascular system

Mesh:

Year:  2019        PMID: 31563225     DOI: 10.1016/j.ncl.2019.07.008

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  29 in total

1.  Comparative Efficacy of Oral Calcitonin-Gene-Related Peptide Antagonists for the Treatment of Acute Migraine: Updated Meta-analysis.

Authors:  Jae-Hwan Kwak; In-Hwan Baek; Dong Kyoung Ha; Min Ji Kim; Nayoung Han
Journal:  Clin Drug Investig       Date:  2021-01-11       Impact factor: 2.859

2.  Association of dietary diversity score (DDS) and migraine headache severity among women.

Authors:  Faezeh Khorsha; Atieh Mirzababaei; Mansoureh Togha; Khadijeh Mirzaei
Journal:  Neurol Sci       Date:  2021-01-11       Impact factor: 3.307

3.  VDR Gene Polymorphisms and Cluster Headache Susceptibility: Case-Control Study in a Southeastern European Caucasian Population.

Authors:  Maria Papasavva; Michail Vikelis; Vasileios Siokas; Martha-Spyridoula Katsarou; Emmanouil Dermitzakis; Athanasios Raptis; Efthimios Dardiotis; Nikolaos Drakoulis
Journal:  J Mol Neurosci       Date:  2021-09-14       Impact factor: 3.444

Review 4.  A Comprehensive Review of Zavegepant as Abortive Treatment for Migraine.

Authors:  Nazir Noor; Alexis Angelette; Abby Lawson; Anjana Patel; Ivan Urits; Omar Viswanath; Cyrus Yazdi; Alan D Kaye
Journal:  Health Psychol Res       Date:  2022-06-28

Review 5.  Headache and Autonomic Dysfunction: a Review.

Authors:  Courtney Iser; Karissa Arca
Journal:  Curr Neurol Neurosci Rep       Date:  2022-08-22       Impact factor: 6.030

6.  Safety evaluation of oral calcitonin-gene-related peptide receptor antagonists in patients with acute migraine: a systematic review and meta-analysis.

Authors:  Nayoung Han; In-Hwan Baek; Seoyeon Lee; Christine E Staatz
Journal:  Eur J Clin Pharmacol       Date:  2022-06-22       Impact factor: 3.064

7.  Association between migraine and risk of ocular motor cranial nerve palsy.

Authors:  Soolienah Rhiu; Kyungdo Han; Juhwan Yoo; Kyung-Ah Park; Sei Yeul Oh
Journal:  Sci Rep       Date:  2022-06-22       Impact factor: 4.996

8.  Erenumab in highly therapy-refractory migraine patients: First German real-world evidence.

Authors:  Armin Scheffler; Olga Messel; Sebastian Wurthmann; Michael Nsaka; Christoph Kleinschnitz; Martin Glas; Steffen Naegel; Dagny Holle
Journal:  J Headache Pain       Date:  2020-07-03       Impact factor: 7.277

Review 9.  The Role of Vitamin D in Primary Headache-from Potential Mechanism to Treatment.

Authors:  Magdalena Nowaczewska; Michał Wiciński; Stanisław Osiński; Henryk Kaźmierczak
Journal:  Nutrients       Date:  2020-01-17       Impact factor: 5.717

10.  A novel, injury-free rodent model of vulnerability for assessment of acute and preventive therapies reveals temporal contributions of CGRP-receptor activation in migraine-like pain.

Authors:  Caroline M Kopruszinski; Edita Navratilova; Juliana Swiokla; David W Dodick; Iain P Chessell; Frank Porreca
Journal:  Cephalalgia       Date:  2020-09-26       Impact factor: 6.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.